Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue
about
Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerMAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerA kernel-based integration of genome-wide data for clinical decision support.T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinomaCancer/testis antigens and urological malignanciesDirections in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Targeting tumours by adoptive transfer of immune cells.Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Inducible expression of cancer-testis antigens in human prostate cancer.Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens.DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.Cancer/testis antigen SPATA19 is frequently expressed in benign prostatic hyperplasia and prostate cancer.Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.[Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].MAGE-A antigens in lesions of the oral mucosa.
P2860
Q26852766-D74605A9-8589-4535-88AB-2C9F4F211C72Q28478930-E77349F5-D878-4ECB-A153-523F33F5BAF5Q33428301-48655255-EB8B-49FA-BDE7-2E3B04E8763CQ33530527-EDA42CEF-8275-42E2-BAD8-715E94CEA1B8Q34474138-013DA67F-64E2-4A73-9D02-F0C190A5A304Q34503895-78CB6C93-C0E8-4FB4-9DD1-73A207942151Q35197347-8B80A6E7-2B44-499C-B64D-D2A9FF69FA71Q36337004-B59EB4E9-8BB0-4825-AACF-6A4EAEC96F0FQ36471827-2B079463-DBEC-42CC-9FA9-3B12045EE0CAQ36478870-6F110FE5-AC84-4114-919A-DFA5BDC738BCQ36918233-71FD2A33-4482-44BD-A10D-0FE44443E7ACQ37686238-7C73A04F-4C14-4C14-9909-AF394A82E698Q38207592-7C3A6506-95C4-458A-A903-A48FE91F1382Q38212231-6BA5AE35-BBFD-4E68-9317-83943BDC7368Q38445350-53BBFC30-7AD0-4CD5-B3C8-3E3E482D1227Q39383424-29EA1BFA-8DFF-487C-BC88-1EF7BC4635FCQ39610714-BF1E011B-FFFA-4CBB-9A6A-55BF203090ADQ39923092-13E21156-DF14-413D-9ECD-691132FAA62BQ47708668-F170A8D4-10C5-48A4-851B-690EFB9430DEQ48135793-D1F82D1E-01BC-4456-BF2F-A36393080F29Q49335269-0783E5C1-82BE-45E6-BD99-5D4EBA1F0294Q53209590-65D438A7-6487-43CB-A72E-2342F85F544AQ53301702-D2C48EA3-8A6D-41A5-9B8E-5B59325777E6
P2860
Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immunohistochemical expression ...... us and benign prostatic tissue
@ast
Immunohistochemical expression ...... us and benign prostatic tissue
@en
Immunohistochemical expression ...... us and benign prostatic tissue
@nl
type
label
Immunohistochemical expression ...... us and benign prostatic tissue
@ast
Immunohistochemical expression ...... us and benign prostatic tissue
@en
Immunohistochemical expression ...... us and benign prostatic tissue
@nl
prefLabel
Immunohistochemical expression ...... us and benign prostatic tissue
@ast
Immunohistochemical expression ...... us and benign prostatic tissue
@en
Immunohistochemical expression ...... us and benign prostatic tissue
@nl
P2093
P3181
P356
P1433
P1476
Immunohistochemical expression ...... us and benign prostatic tissue
@en
P2093
Antonio Juretic
Daniela Bandic
Giulio Cesare Spagnoli
Josip Pasini
Michael Heberer
Miljenko Kosicek
Mirjana Cacic
Tvrtko Hudolin
P3181
P356
10.1002/PROS.20312
P407
P577
2006-01-01T00:00:00Z